FDG–PET in the prediction of survival of patients with cancer of the pancreas: a pilot study

Reporting results of cancer treatment

1981 • 7,916 citations

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

1997 • 5,683 citations

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1996 • 781 citations

Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients

1996 • 537 citations

Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990

1997 • 535 citations

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose

1996 • 499 citations

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1998 • 335 citations

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.

1996 • 318 citations

Chemotherapy prolongs survival in inoperable pancreatic carcinoma

1994 • 265 citations

Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.

1992 • 245 citations

Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

1997 • 237 citations

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1998 • 231 citations

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.

1994 • 218 citations

Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases

1997 • 204 citations

Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.

1997 • 197 citations

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.

1995 • 151 citations

Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.

1997 • 151 citations

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.

1993 • 149 citations

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

1997 • 128 citations

Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy.

1993 • 111 citations

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?

1995 • 93 citations

18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma

1997 • 85 citations

FDG-PET for predicting the prognosis of malignant lymphoma

1994 • 68 citations

Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study

1997 • 58 citations

The performance of a multiwire proportional chamber positron camera for clinical use

1989 • 53 citations

Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.

1995 • 44 citations

Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET.

1999 • 39 citations

Cisplatin and protracted venous infusion 5-fluorouracil (CF) — good symptom relief with low toxicity in advanced pancreatic carcinoma

1995 • 38 citations

Non-focal enlargement in pancreatic carcinoma.

1982 • 35 citations

FDG-PET for the evaluation of tumor viability after anticancer therapy

1994 • 17 citations

Multimodality image registration and its application to the dosimetry of intralesional radionuclide therapy.

1995 • 5 citations